Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Perinatal Disaster Management

By ACEP Now | on September 1, 2011 | 0 Comment
CME CME Now
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Bone Marrow Recovery

Neupogen31: Children and pregnant women should take Neupogen with caution. It is not known if Neupogen is excreted in human milk, so breastfeeding women should take Neupogen with caution as well.

You Might Also Like
  • Perinatal Disaster Management
  • Critical Issues in the Initial Evaluation and Management of Patients Presenting to the Emergency Department in Early Pregnancy
  • No Birth Defects Seen in Babies Exposed to Zika Late in Pregnancy: Study
Explore This Issue
ACEP News: Vol 30 – No 09 – September 2011

Plutonium, Americium, and Curium

DTPA32: Infants (including breastfed infants) and children younger than 12 years of age: Either Ca-DTPA or Zn-DTPA may be given to infants and children. The dosage of DTPA to be given should be based on the child’s size and weight.

Pregnant women: Unless a pregnant woman has very high levels of internal contamination with plutonium, americium, or curium, treatment should begin and continue with Zn-DTPA.

Ca-DTPA should be used in pregnant women only to treat very high levels of internal radioactive contamination. In this case, doctors and public health authorities may prescribe a single dose of Ca-DTPA, together with a vitamin and mineral supplement that contains zinc, as the first treatment. However, after the first dose of Ca-DTPA, treatment should continue 24 hours later with a daily dose of Zn-DTPA, as needed.

Breastfeeding women: Radioactive materials can and do get into breast milk. For this reason, the CDC recommends that women with internal contamination stop breastfeeding and feed the child baby formula or other food if it is available. If breast milk is the only food available for an infant, nursing should continue. Breastfeeding women who are internally contaminated with plutonium, americium, or curium should be treated with DTPA.

Cesium and Thallium

Prussian blue33: Since the 1960s, Prussian blue has been used to treat people who have been internally contaminated with radioactive cesium (mainly Cs-137) and nonradioactive thallium (once an ingredient in rat poisons). Doctors can prescribe Prussian blue at any point after they have determined that a person who is internally contaminated would benefit from treatment. Prussian blue will help speed up the removal of cesium and thallium from the body. The drug is safe for most adults, including pregnant women, and children (2-12 years). Dosing for infants (0-2 years) has not been determined yet.

Women who are breastfeeding their babies should stop breastfeeding if they think they are contaminated with radioactive materials and consult with their doctors.

People who have had constipation, blockages in the intestines, or certain stomach problems should be sure to tell their doctors before taking Prussian blue. Before taking Prussian blue, people also should be sure to tell their doctors about any other medicine they are taking.

Pages: 1 2 3 4 5 6 7 8 | Single Page

Topics: ACEPAmerican College of Emergency PhysiciansAntibioticCMECritical CareDisaster MedicineEducationEmergency MedicineEmergency PhysicianInfectious DiseaseNeurologyOB/GYNPregnancyProcedures and SkillsRadiation EmergencyTransfusion

Related

  • 10 Essentials for Your Emergency Department Fanny Pack

    June 17, 2025 - 0 Comment
  • Case Report: When Syncope Gets Hairy

    June 17, 2025 - 0 Comment
  • New Recommendations for Administering RhD IG at Less than 12 Weeks

    May 7, 2025 - 0 Comment

Current Issue

ACEP Now: June 2025 (Digital)

Read More

About the Author

ACEP Now

View this author's posts »

No Responses to “Perinatal Disaster Management”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603